Premium Macular Carotenoid Supplements for Indian Seniors
The Opportunity
India's rapidly aging population (65+ cohort growing 3% annually) lacks affordable, branded lutein and zeaxanthin supplements specifically formulated for AMD prevention. The article reveals strong clinical evidence supporting these nutrients, yet no Indian brand dominates the senior eye-health segment. Seniors rely on generic imports or unregulated formulations.
Market Size
₹850–1,200 crore (India's nutraceuticals market for seniors; eye-health subset estimated ₹120–180 crore and growing 12% CAGR). Source: ASSOCHAM, Allied Market Research.
Business Model
Manufacture and distribute branded capsule/tablet supplements containing lutein, zeaxanthin, and meso-zeaxanthin (sourced from suppliers) under your own label. Sell via online (Amazon/Flipkart), pharmacies, geriatric clinics, and senior care homes. Position as 'Seniors Today recommended' or clinical-grade brand.
Direct e-commerce sales (₹8–12/month per customer × 50,000 customers = ₹4.8–7.2 cr/year); B2B pharmacy distribution (20–25% margin on ₹2–3 crore wholesale); institutional contracts with old-age homes and hospitals (₹40–80 lakh/year).
Your 30-Day Action Plan
Identify 3–4 Indian nutraceutical co-packers with GMP/ISO certification and get ingredient quotes (lutein, zeaxanthin, meso-zeaxanthin).
File trademark and consult food lawyer on FSSAI pre-registration requirements; finalize formulation and packaging design.
Order pilot batch (5,000–10,000 units); set up e-commerce storefront and approach 5–8 pharmacy chains with samples.
Conduct pre-launch email campaign targeting 'Seniors Today' readers; establish Amazon/Flipkart seller account and list product.
Compliance & Regulatory Angle
FSSAI license (nutraceutical supplement category), GMP certification, third-party lab testing for potency/purity, GST @ 5% (nutraceuticals), labeling per Food Safety Standards. No import duty if sourced domestically; 10% if ingredients imported and repackaged.
Ready to Act on This Opportunity?
Generate a 7-step execution plan — validate the market, build the MVP, model the financials, map the risks, and ship in 30 days.